Nifedipine Tablet, Extended Release
Product Images NDC 51655-780

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 51655-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 780 52 Master Bottle Label Approval Rev A 08 21)

Label (51655 780 52 Master Bottle Label Approval   Rev A 08 21)
NIFEdipine A is an extended-release tablet used for medication that comes in a 60 bottle containing 30 tablets. This drug is only available with a prescription and should be stored in the original container at USP Controlled Room Temperature zones. It is suggested to store the medication at temperatures between 20°C-25°C (68°-77°F) and protect it from light and moisture. It is recommended to swallow tablets whole and not to divide them, bite them, or give them to children who are under the age of 18.*
FDA Label Image

Image1 (Image 01)

FDA Label Image

Image2 (Image 02)

Image2 (Image 02)
The text provides mean reductions in trough supine blood pressure (mmHg) for Nifedipine ER (Nifedipine extended-release tablets) in two studies. The reductions in systolic/diastolic blood pressure for different doses of medication are provided in each study. This data can be useful in understanding the effect of the medication on reducing blood pressure.*
FDA Label Image

Image3 (Image 03)

Image3 (Image 03)
This is a table showing the percentage of adverse effects experienced by patients taking Nifedipine extended-release tablets compared to those taking a placebo, based on a sample size of 370 and 126 respectively. The adverse effects listed include headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation.*
FDA Label Image

Image4 (Image 04)

Image4 (Image 04)
These are Novast branded pills with different strengths and color markings. The yellow pill is 30 mg and has "Novast" imprinted on one side and "33" on the other side. The pink pill is 60 mg and has "Novast" imprinted on one side and "36" on the other side. The brown pill is 90 mg and has "Novast" imprinted on one side and "39" on the other side.*
FDA Label Image

Image6 (Image 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.